$19.32
7.34% yesterday
NYSE, Nov 15, 10:19 pm CET
ISIN
US4330001060
Symbol
HIMS

Hims & Hers Health Inc. Stock price

$19.32
-3.48 15.26% 1M
+5.48 39.60% 6M
+10.42 117.08% YTD
+11.61 150.58% 1Y
+11.15 136.47% 3Y
+9.42 95.15% 5Y
+9.52 97.14% 10Y
NYSE, Closing price Fri, Nov 15 2024
-1.53 7.34%
ISIN
US4330001060
Symbol
HIMS
Industry

Key metrics

Market capitalization $4.22b
Enterprise Value $3.98b
P/E (TTM) P/E ratio 44.69
EV/FCF (TTM) EV/FCF 26.59
EV/Sales (TTM) EV/Sales 3.20
P/S ratio (TTM) P/S ratio 3.40
P/B ratio (TTM) P/B ratio 9.56
Revenue growth (TTM) Revenue growth 56.70%
Revenue (TTM) Revenue $1.24b
EBIT (operating result TTM) EBIT $36.52m
Free Cash Flow (TTM) Free Cash Flow $149.62m
Cash position $254.07m
EPS (TTM) EPS $0.43
P/E forward 39.02
P/S forward 3.12
EV/Sales forward 2.96
Short interest 17.71%
Show more

Is Hims & Hers Health Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,897 stocks worldwide.

Hims & Hers Health Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

13 Analysts have issued a Hims & Hers Health Inc. forecast:

5x Buy
38%
7x Hold
54%
1x Sell
8%

Analyst Opinions

13 Analysts have issued a Hims & Hers Health Inc. forecast:

Buy
38%
Hold
54%
Sell
8%

Financial data from Hims & Hers Health Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
1,242 1,242
57% 57%
100%
- Direct Costs 365 365
131% 131%
29%
877 877
38% 38%
71%
- Selling and Administrative Expenses 827 827
24% 24%
67%
- Research and Development Expense - -
-
-
50 50
252% 252%
4%
- Depreciation and Amortization 14 14
54% 54%
1%
EBIT (Operating Income) EBIT 37 37
187% 187%
3%
Net Profit 101 101
384% 384%
8%

In millions USD.

Don't miss a Thing! We will send you all news about Hims & Hers Health Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Hims & Hers Health Inc. Stock News

Neutral
Seeking Alpha
about 8 hours ago
Hims & Hers Health, Inc.'s stock dropped over 25% over the last 2 days due to Amazon's entry into the hair loss and ED markets, but I believe investor pessimism is overblown. Despite Amazon's competition, Hims & Hers's focus on personalized solutions, which saw 175% YoY growth, provides a strong competitive moat. Even with conservative growth estimates, Hims & Hers has a 38% upside potential, m...
Negative
Fast Company
about 13 hours ago
Hims & Hers Health, a telehealth service for clients to access healthcare and prescriptions from home, is seeing its stock take a steep dive on Thursday, just after Amazon announced updates to a strikingly similar service for Prime members.
Neutral
Market Watch
one day ago
Amazon is now offering upfront pricing for virtual care for ailments such as men's hair loss and ED.
More Hims & Hers Health Inc. News

Company Profile

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Head office United States
CEO Andrew Dudum
Employees 1,046
Founded 2017
Website www.forhims.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today